S&P 500   2,619.36 (+3.06%)
DOW   22,236.36 (+2.77%)
QQQ   191.94 (+3.58%)
AAPL   254.56 (+2.75%)
FB   165.73 (+5.70%)
AMZN   1,953.68 (+2.82%)
NVDA   264.62 (+4.70%)
BABA   189.91 (+0.70%)
MU   44.39 (+2.09%)
GE   7.92 (+3.80%)
TSLA   506.36 (-1.56%)
AMD   47.84 (+2.71%)
T   30.15 (+1.04%)
ACB   0.88 (-14.54%)
F   5.01 (-3.66%)
NFLX   373.30 (+4.53%)
BAC   22.26 (+3.06%)
GILD   75.72 (+3.94%)
DIS   98.90 (+2.59%)
S&P 500   2,619.36 (+3.06%)
DOW   22,236.36 (+2.77%)
QQQ   191.94 (+3.58%)
AAPL   254.56 (+2.75%)
FB   165.73 (+5.70%)
AMZN   1,953.68 (+2.82%)
NVDA   264.62 (+4.70%)
BABA   189.91 (+0.70%)
MU   44.39 (+2.09%)
GE   7.92 (+3.80%)
TSLA   506.36 (-1.56%)
AMD   47.84 (+2.71%)
T   30.15 (+1.04%)
ACB   0.88 (-14.54%)
F   5.01 (-3.66%)
NFLX   373.30 (+4.53%)
BAC   22.26 (+3.06%)
GILD   75.72 (+3.94%)
DIS   98.90 (+2.59%)
S&P 500   2,619.36 (+3.06%)
DOW   22,236.36 (+2.77%)
QQQ   191.94 (+3.58%)
AAPL   254.56 (+2.75%)
FB   165.73 (+5.70%)
AMZN   1,953.68 (+2.82%)
NVDA   264.62 (+4.70%)
BABA   189.91 (+0.70%)
MU   44.39 (+2.09%)
GE   7.92 (+3.80%)
TSLA   506.36 (-1.56%)
AMD   47.84 (+2.71%)
T   30.15 (+1.04%)
ACB   0.88 (-14.54%)
F   5.01 (-3.66%)
NFLX   373.30 (+4.53%)
BAC   22.26 (+3.06%)
GILD   75.72 (+3.94%)
DIS   98.90 (+2.59%)
S&P 500   2,619.36 (+3.06%)
DOW   22,236.36 (+2.77%)
QQQ   191.94 (+3.58%)
AAPL   254.56 (+2.75%)
FB   165.73 (+5.70%)
AMZN   1,953.68 (+2.82%)
NVDA   264.62 (+4.70%)
BABA   189.91 (+0.70%)
MU   44.39 (+2.09%)
GE   7.92 (+3.80%)
TSLA   506.36 (-1.56%)
AMD   47.84 (+2.71%)
T   30.15 (+1.04%)
ACB   0.88 (-14.54%)
F   5.01 (-3.66%)
NFLX   373.30 (+4.53%)
BAC   22.26 (+3.06%)
GILD   75.72 (+3.94%)
DIS   98.90 (+2.59%)
Log in

NYSE:SNY - Sanofi Stock Price, Forecast & News

$44.72
+2.28 (+5.37 %)
(As of 03/30/2020 03:18 PM ET)
Today's Range
$43.52
Now: $44.72
$45.37
50-Day Range
$38.02
MA: $46.86
$51.66
52-Week Range
$37.62
Now: $44.72
$51.84
Volume4.76 million shs
Average Volume2.40 million shs
Market Capitalization$111.99 billion
P/E Ratio14.29
Dividend Yield2.70%
Beta0.67
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Read More
Sanofi logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$39.60 billion
Cash Flow$4.91 per share
Book Value$26.11 per share

Profitability

Net Income$4.28 billion

Miscellaneous

EmployeesN/A
Outstanding Shares2,504,138,000
Market Cap$111.99 billion
Next Earnings Date4/24/2020 (Confirmed)
OptionableOptionable

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.


Sanofi (NYSE:SNY) Frequently Asked Questions

How has Sanofi's stock been impacted by COVID-19 (Coronavirus)?

Sanofi's stock was trading at $44.79 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SNY stock has decreased by 0.2% and is now trading at $44.72. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sanofi?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sanofi.

When is Sanofi's next earnings date?

Sanofi is scheduled to release its next quarterly earnings announcement on Friday, April 24th 2020. View our earnings forecast for Sanofi.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) announced its quarterly earnings results on Thursday, February, 6th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.04. The business earned $10.64 billion during the quarter, compared to analyst estimates of $11.12 billion. Sanofi had a return on equity of 18.18% and a net margin of 12.20%. View Sanofi's earnings history.

What guidance has Sanofi issued on next quarter's earnings?

Sanofi issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided EPS guidance of 6.05-6.05 for the period.

What price target have analysts set for SNY?

11 analysts have issued 1-year price objectives for Sanofi's shares. Their forecasts range from $52.00 to $58.00. On average, they anticipate Sanofi's share price to reach $55.33 in the next twelve months. This suggests a possible upside of 23.7% from the stock's current price. View analysts' price targets for Sanofi.

Has Sanofi been receiving favorable news coverage?

Media headlines about SNY stock have trended very positive recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sanofi earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutSanofi.

Who are some of Sanofi's key competitors?

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Gilead Sciences (GILD), Johnson & Johnson (JNJ), AT&T (T), Merck & Co., Inc. (MRK), Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Walt Disney (DIS), Exxon Mobil (XOM) and Bank of America (BAC).

Who are Sanofi's key executives?

Sanofi's management team includes the following people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 53)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include FMR LLC (0.42%), Bank of America Corp DE (0.29%), Hotchkis & Wiley Capital Management LLC (0.14%), Macquarie Group Ltd. (0.13%), Macquarie Group Ltd. (0.13%) and Hamlin Capital Management LLC (0.07%). View institutional ownership trends for Sanofi.

Which major investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Point72 Asset Management L.P., Brandes Investment Partners LP, Alliancebernstein L.P., Baird Financial Group Inc., Schonfeld Strategic Advisors LLC, Franklin Resources Inc., and Franklin Resources Inc.. View insider buying and selling activity for Sanofi.

Which major investors are buying Sanofi stock?

SNY stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Bank of America Corp DE, Cambiar Investors LLC, Hotchkis & Wiley Capital Management LLC, Credit Suisse AG, Marshall Wace LLP, Schafer Cullen Capital Management Inc, and Natixis Advisors L.P.. View insider buying and selling activity for Sanofi.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $44.72.

How big of a company is Sanofi?

Sanofi has a market capitalization of $111.99 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis.  View additional information about Sanofi.

What is Sanofi's official website?

The official website for Sanofi is http://www.sanofi.com/.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]


MarketBeat Community Rating for Sanofi (NYSE SNY)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  468 (Vote Outperform)
Underperform Votes:  567 (Vote Underperform)
Total Votes:  1,035
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel